AKR1A1
Reaktivität: Human
WB
Wirt: Maus
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Singer, Herth, Kuhlmann, Holland-Nell, Beck-Sickinger, Hoffmann: "Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation." in: Biochemical and biophysical research communications, Vol. 367, Issue 2, pp. 318-22, (2008) (PubMed).
Bains, Takahashi, Pfeifer, Grigliatti, Reid, Riggs: "Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 36, Issue 5, pp. 904-10, (2008) (PubMed).
Takahashi, Bains, Pfeifer, Grigliatti, Reid, Riggs: "Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 36, Issue 6, pp. 991-4, (2008) (PubMed).
Target
AKR1A1
(Aldo-Keto Reductase Family 1, Member A1 (Aldehyde Reductase) (AKR1A1))